STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more

The US is pressuring Germany to pay more for pharmaceuticals, while some US biotech companies consider moving trials outside the country due to FDA upheaval. The Trump administration is pushing for other countries to pay more for medications as the US pays less. This move may lead to delays in regulatory reviews and changes in traditional pathways for bringing new medicines to market.